Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3875-3881

  Yan, Kang ^a   Madden, Lenore ^a   Choudhry, Anthony E ^a   Voigt, Christine S ^a,b   Copeland, Robert A ^a   Gontarek, Richard R ^a  

^a GLAXOSMITHKLINE   (United States)

^b Global Health Outcomes and Market Access   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DITERPENE; PEPTIDYLTRANSFERASE; PLEUROMUTILIN DERIVATIVE; SB 258781 AAA; SB 268091; SB 275833; SB 452466; TIAMULIN; TRANSFER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL SKIN DISEASE; BINDING AFFINITY; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CLASSIFICATION; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; ENZYME INHIBITION; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RIBOSOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BICYCLO COMPOUNDS, HETEROCYCLIC; DITERPENES; ESCHERICHIA COLI; FLUORESCENT DYES; LIGANDS; LUCIFERASES; PROTEIN BIOSYNTHESIS; PUROMYCIN; RABBITS; RETICULOCYTES; RIBOSOMES; RNA, MESSENGER; RNA, RIBOSOMAL;

EID: 33750600405     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00184-06     Document Type: Article

References (23)

1. Berry, V., S. Dabbs, H. C. Frydrych, E. Hunt, G. Woodnntt, and D. F. Sanderson. May 1999. Pleuromutilin derivatives as antimicrobials. International patent WO99/21855.
2. Brooks, G., W. Burgess, D. Colthurst, J. D. Hinks, E. Hunt, M. J. Pearson, B. Shea, A. K. Takle, J. M. Wilson, and G. Woodnutt. 2001. Pleuromutilins. Part 1. The identification of novel mutilin 14-carbamates. Bioorg. Med. Chem. 9:1221-1231.
3. Copeland, R. A. 2005. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. John Wiley & Sons, Inc., Hoboken, N.J.
4. Gould, P. S., H. Bird, and A. J. Easton. 2005. Translation teleprinting assays using fluorescently labeled primers and capillary electrophoresis. BioTechniques 38:397-400.
5. Hodgin, L. A., and G. Hogenaner. 1974. The mode of action of pleuromutilin derivatives. Effect on cell-free polypeptide synthesis. Eur. J. Biochem. 47:527-533.
6. Hogenauer, G. 1975. The mode of action of pleuromutilin derivatives. Location and properties of the pleuromutilin binding site on Escherichia coli ribosomes. Eur. J. Biochem. 52:93-98.
7. Hunt, E. 2000. Pleuromutilin antibiotics. Drugs Future 25:1163-1168.
8. Kavanagh, F., A. Hervey, and W. J. Robbins. 1951. Antibiotic substances from Basidiomycetes. VIII. Pleurotus multilus (fr.) Sacc. and Pleurotus Passeckerianus Pilat. Proc. Natl. Acad. Sci. USA 37:570-574.
9. Kosowska-Shick, K., C. Clark, K. Credito, P. McGhee, B. Dewasse, T. Bogdanovich, and P. C. Appelbaum. 2006. Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrob. Agents Chemother. 50:765-769.
10. Moazed, D., and H. F. Noller. 1989. Interaction of tRNA with 23S rRNA in the ribosomal A, P, and E sites. Cell 57:585-597.
11. Motulsky, H. J., and L. C. Mahan. 1984. The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25:1-9.
12. Polacek, N., S. Swaney, D. Shinabarger, and A. S. Mankin. 2002. SPARK-a novel method to monitor ribosomal peptidyl transferase activity. Biochemistry 41:11602-11610.
13. Poulsen, S. M., M. Karlsson, L. B. Johansson, and B. Vester. 2001. The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome. Mol. Microbiol. 41:1091-1099.
14. Pringle, M., J. Poehlsgaard, B. Vester, and K. S. Long. 2004. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol. Microbiol. 54:1295-1306.
15. Rittenhonse, S., C. Singley, J. Hoover, R. Page, and D. Payne. 2006. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic. Antimicrob. Agents Chemother. 50:3886-3888.
16. Rittenhouse, S., S. Biswas, J. Broskey, L. McCloskey, T. Moore, S. Vasey, J. West, M. Zalacain, R. Zonis, and D. Payne. 2006. Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob. Agents Chemother. 50:3882-3885.
17. Schlunzen, F., E. Pyetan, P. Fucini, A. Yonath, and J. M. Harms. 2004. Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Mol. Microbiol. 54:1287-1294.
18. Schlünzen, F., R. Zarivach, J. Harms, A. Bashan, A. Tocij, R. Albrecht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821.
19. Schwartz, I., and J. Ofengand. 1978. Photochemical cross-linking of unmodified acetylvalyl-tRNA to 16S RNA at the ribosomal P site. Biochemistry 17:2524-2530.
20. Springer, D. M., M. E. Sorenson, S. Huang, T. P. Connolly, J. J. Bronson, J. A. Matson, R. L. Hanson, D. B. Brzozowski, T. L. LaPorte, and R. N. Patel. 2003. Synthesis and activity of a C-8 keto pleuromutilin derivative. Bioorg. Med. Chem. Lett. 13:1751-1753.
21. Staehelin, T., and D. T. Maglott. 1971. Preparation of Escherichia coli ribosomal subunits active in polypeptide synthesis. Methods Enzymol. 20:449-456.
22. Tenson, T., M. Lovmar, and M. Ehrenberg. 2003. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 330:1005-1014.
23. Van, K., E. Hunt, J. Berge, E. May, R. A. Copeland, and R. R. Gontarek. 2005. Fluorescence polarization method to characterize macrolide-ribosome interactions. Antimicrob. Agents Chemother. 49:3367-3372.